Concepedia

Meir Schechter

MS

Statistics

Publications

17

Citations

687

H-Index

15

Active since

2015

Affiliations

Hebrew University of Jerusalem(Current)

Hadassah Medical Center

University Medical Center Groningen

University of Groningen

AstraZeneca (Sweden)

Meir Schechter is an author at Hebrew University of Jerusalem specializing in cardiovascular disease, diabetes, and metabolic syndrome.

ORCID

Top concepts

Publications per year

2015–2023

17

Publications

17

α-Synuclein Translocates to the Nucleus to Activate Retinoic-Acid-Dependent Gene Transcription

Dana Davidi, Meir Schechter, Suaad Abd Elhadi et al. · iScience · 2020 · 105 citations · Full text

The Effect of Dapagliflozin on Albuminuria in DECLARE-TIMI 58

Ofri Mosenzon, Stephen D. Wiviott, Hiddo J.L. Heerspink et al. · Diabetes Care · 2021 · 101 citations · Full text

Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial

Ofri Mosenzon, Itamar Raz, Stephen D. Wiviott et al. · Diabetes Care · 2022 · 60 citations · Full text

Dapagliflozin and Anemia in Patients with Chronic Kidney Disease

Akihiko Koshino, Meir Schechter, Glenn M. Chertow et al. · NEJM Evidence · 2023 · 60 citations · Full text

Total and Proteinase K-Resistant α-Synuclein Levels in Erythrocytes, Determined by their Ability to Bind Phospholipids, Associate with Parkinson’s Disease

Suaad Abd-Elhadi, Asaf Honig, Dganit Simhi-Haham et al. · Scientific Reports · 2015 · 54 citations · Full text

1–5 of 17